Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center Analysis

SIMPLE SUMMARY: The analysis of prognostic biomarkers (e.g., PD-L1) helps to define treatment for lung cancer patients. To date, these markers have only been examined in metastatic or inoperable situations. We analyzed the PD-L1 expression-levels of tumors from 277 lung cancer patients that underwen...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichhorn, Florian, Kriegsmann, Mark, Klotz, Laura V., Kriegsmann, Katharina, Muley, Thomas, Zgorzelski, Christiane, Christopoulos, Petros, Winter, Hauke, Eichhorn, Martin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122862/
https://www.ncbi.nlm.nih.gov/pubmed/33922610
http://dx.doi.org/10.3390/cancers13092046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122862/
https://www.ncbi.nlm.nih.gov/pubmed/33922610
http://dx.doi.org/10.3390/cancers13092046

Ejemplares similares